Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SP-16 by Serpin Pharma for Acute Lung Injury: Likelihood of Approval
SP-16 is under clinical development by Serpin Pharma and currently in Phase II for Acute Lung Injury. According to GlobalData,...